Home
>
National Drug Code (NDC)
>
TAZORAC
TAZORAC - 0023-3091-15 - (tazarotene)
Drug Information of TAZORAC
| Product NDC: | 0023-3091 |
| Proprietary Name: | TAZORAC |
| Non Proprietary Name: | tazarotene |
| Active Ingredient(s): | .5 mg/g & nbsp; tazarotene |
| Administration Route(s): | CUTANEOUS |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TAZORAC
| Product NDC: | 0023-3091 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020600 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970801 |
Package Information of TAZORAC
| Package NDC: | 0023-3091-15 |
| Package Description: | 15 TUBE in 1 CARTON (0023-3091-15) > 3.5 g in 1 TUBE |
NDC Information of TAZORAC
| NDC Code | 0023-3091-15 |
| Proprietary Name | TAZORAC |
| Package Description | 15 TUBE in 1 CARTON (0023-3091-15) > 3.5 g in 1 TUBE |
| Product NDC | 0023-3091 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tazarotene |
| Dosage Form Name | GEL |
| Route Name | CUTANEOUS |
| Start Marketing Date | 19970801 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | TAZAROTENE |
| Strength Number | .5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
